This graphic illustrates a potential breakthrough in the treatment of heart failure patients. The C-Pulse system utilizes a cuff that`s placed around the aorta and hooked via wires to an external power source. The system is synced with a patient`s pulse so that it quickly inflates after each heartbeat to help squeeze blood out of the heart. A new study led by researchers at The Ohio State University Wexner Medical Center shows that the device slowed or reversed symptoms in several heart failure patients during the first round of tests in the United States. Credit: Sunshine Heart Inc.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, according to lead researcher Dr. William Abraham of The Ohio State University Wexner Medical Center.
Results of the study are published in the Journal of American College of Cardiology Heart Failure.
"Heart failure is one of the fastest growing forms of heart disease and it's one of the most common reasons people are hospitalized," said Abraham, director of the Division of Cardiovascular Medicine at Ohio State's Wexner Medical Center. "The optimal drug therapies we have today often aren't enough to manage this disease for some patients, so we are always looking for new types of therapies."
Abraham and other cardiovascular researchers at seven U.S. centers examined an extra-aortic counterpulsation system called C-Pulse, made by Sunshine Heart Inc. It's a cuff that wraps around the aorta and syncs with the patient's heartbeat, rapidly inflating and deflating a small balloon to help squeeze blood through the aorta to circulate throughout the body. It's powered through a wire that exits the abdomen and connects to an external driver worn by the patient. The driver can be plugged in or battery-powered.
In the pilot study, 20 patients with New York Heart Association (NYHA) functional class III or ambulatory functional class IV heart failure were implanted with the device. Patients were evaluated at six months and one year. At both times, 16 of the patients showed significant improvements in NYHA functional class.
"At the one year mark, three of the patients had mild or no symptoms of heart failure. They went from class III or IV down to a functional class I, effectively reversing their heart failure," Abraham said.
This video is not supported by your browser at this time.
Doctors are encouraged by potential breakthrough therapy for heart failure. Dr. William Abraham listens to the heart of Richard Jacob at The Ohio State University Wexner Medical Center. Jacob was the first heart failure patient in the US to test an experimental device known as C-Pulse. Dr. Abraham has authored a new study showing that the device slowed or reversed the symptoms of heart failure in several patients, boosting their stamina and often doubling their quality of life scores. Credit: The Ohio State University
Additionally, patients were able to walk an average 100 feet farther during standardized measures and average quality of life scores improved nearly 30 points. "Drug and device therapies that are currently available for heart failure improve that same quality of life score by only five or 10 points. So, this is truly a significant improvement," Abraham said.
The most common adverse effect during the trial was infection of the exit site, experienced by 8 out of 20 participants. Researchers noted that stricter guidelines for exit site management, wound care and antibiotic therapy could reduce that risk in future studies.
There were no hospitalizations among the participants for stroke, thrombosis, sepsis or bleeding, which often occurs in patients using left ventricular assist devices (LVADs). The researchers said this is due to the device remaining outside the bloodstream. Another important difference is the C-Pulse device can be temporarily turned off and disconnected, allowing patients some conveniences that an LVAD doesn't permit.
Explore further: Remote monitoring device approved for heart patients
Medical Xpress on facebook
Related Stories
Remote monitoring device approved for heart patients
May 29, 2014
(HealthDay)—An implanted wireless device that measures key vital signs in people with heart failure has been approved by the U.S. Food and Drug Administration.
Novel device successfully treats central sleep apnea in heart failure
May 19, 2014
A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress 2014, held 17-20 May in ...
Time to take notice and tackle heart failure
Sep 02, 2014
Experts have sounded a call to action for policy makers at local, national, and international levels to promote heart failure prevention, improve heart failure awareness among healthcare professionals, ensure ...
Study finds implanted device helps patients with central sleep apnea
Sep 23, 2013
A small implant being studied for the treatment of central sleep apnea is showing significant promise, according to study results presented by Dr. William Abraham, director of the Division of Cardiovascular ...
Hospitalizations for heart failure increase CKD patients' risk of kidney failure
Sep 04, 2014
Being hospitalized for heart failure increases kidney disease patients' risks of developing kidney failure or dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of ...
Recommended for you
Current treatment leaves stroke patients at risk
6 hours ago
New research has shown current practices for treating stroke victims may be leaving patients overburdened by their treatment plans putting them at risk of adverse side effects.
Study finds that care lags for people who have a stroke in hospital
15 hours ago
At the first sign of a stroke, time is of the essence. For every minute of delay in treatment, people typically lose almost two million brain cells. Yet a new study presented at the Canadian Stroke Congress reveals that those ...
Innovative stroke patient management system cuts hospital bed usage by more than 25 percent
15 hours ago
An innovative patient management system at the acute stroke unit of Kelowna (BC) General Hospital has reduced the number of stroke patient bed days by more than 25 per cent, according to a study of the system presented at ...
Major bleeds found to be rare for patients with stable CAD
Oct 03, 2014
(HealthDay)—Major bleeding events are rare in patients with stable coronary artery disease (CAD); however, concomitant antiplatelet therapy (APT) when oral anticoagulation is required increases bleeding ...
Genetic test reveals risk of atrial fibrillation and stroke
Oct 03, 2014
Many of those who are genetically predisposed to develop atrial fibrillation, which dramatically raises the risk of stroke, can be identified with a blood test. This is shown by new research from Lund University in Sweden.
Too many stroke patients miss out on the window to regain crucial functions
Oct 03, 2014
Too many stroke patients in Canada are not getting the rehabilitation they need to return to a healthy, active life, according to a new study which will be presented at the Canadian Stroke Congress in Vancouver tomorrow. ...
User comments
© Medical Xpress 2011-2014, Science X network
This graphic illustrates a potential breakthrough in the treatment of heart failure patients. The C-Pulse system utilizes a cuff that`s placed around the aorta and hooked via wires to an external power source. The system is synced with a patient`s pulse so that it quickly inflates after each heartbeat to help squeeze blood out of the heart. A new study led by researchers at The Ohio State University Wexner Medical Center shows that the device slowed or reversed symptoms in several heart failure patients during the first round of tests in the United States. Credit: Sunshine Heart Inc.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, according to lead researcher Dr. William Abraham of The Ohio State University Wexner Medical Center.
Results of the study are published in the Journal of American College of Cardiology Heart Failure.
"Heart failure is one of the fastest growing forms of heart disease and it's one of the most common reasons people are hospitalized," said Abraham, director of the Division of Cardiovascular Medicine at Ohio State's Wexner Medical Center. "The optimal drug therapies we have today often aren't enough to manage this disease for some patients, so we are always looking for new types of therapies."
Abraham and other cardiovascular researchers at seven U.S. centers examined an extra-aortic counterpulsation system called C-Pulse, made by Sunshine Heart Inc. It's a cuff that wraps around the aorta and syncs with the patient's heartbeat, rapidly inflating and deflating a small balloon to help squeeze blood through the aorta to circulate throughout the body. It's powered through a wire that exits the abdomen and connects to an external driver worn by the patient. The driver can be plugged in or battery-powered.
In the pilot study, 20 patients with New York Heart Association (NYHA) functional class III or ambulatory functional class IV heart failure were implanted with the device. Patients were evaluated at six months and one year. At both times, 16 of the patients showed significant improvements in NYHA functional class.
"At the one year mark, three of the patients had mild or no symptoms of heart failure. They went from class III or IV down to a functional class I, effectively reversing their heart failure," Abraham said.
This video is not supported by your browser at this time.
Doctors are encouraged by potential breakthrough therapy for heart failure. Dr. William Abraham listens to the heart of Richard Jacob at The Ohio State University Wexner Medical Center. Jacob was the first heart failure patient in the US to test an experimental device known as C-Pulse. Dr. Abraham has authored a new study showing that the device slowed or reversed the symptoms of heart failure in several patients, boosting their stamina and often doubling their quality of life scores. Credit: The Ohio State University
Additionally, patients were able to walk an average 100 feet farther during standardized measures and average quality of life scores improved nearly 30 points. "Drug and device therapies that are currently available for heart failure improve that same quality of life score by only five or 10 points. So, this is truly a significant improvement," Abraham said.
The most common adverse effect during the trial was infection of the exit site, experienced by 8 out of 20 participants. Researchers noted that stricter guidelines for exit site management, wound care and antibiotic therapy could reduce that risk in future studies.
There were no hospitalizations among the participants for stroke, thrombosis, sepsis or bleeding, which often occurs in patients using left ventricular assist devices (LVADs). The researchers said this is due to the device remaining outside the bloodstream. Another important difference is the C-Pulse device can be temporarily turned off and disconnected, allowing patients some conveniences that an LVAD doesn't permit.
Explore further: Remote monitoring device approved for heart patients
Medical Xpress on facebook
Related Stories
Remote monitoring device approved for heart patients
May 29, 2014
(HealthDay)—An implanted wireless device that measures key vital signs in people with heart failure has been approved by the U.S. Food and Drug Administration.
Novel device successfully treats central sleep apnea in heart failure
May 19, 2014
A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress 2014, held 17-20 May in ...
Time to take notice and tackle heart failure
Sep 02, 2014
Experts have sounded a call to action for policy makers at local, national, and international levels to promote heart failure prevention, improve heart failure awareness among healthcare professionals, ensure ...
Study finds implanted device helps patients with central sleep apnea
Sep 23, 2013
A small implant being studied for the treatment of central sleep apnea is showing significant promise, according to study results presented by Dr. William Abraham, director of the Division of Cardiovascular ...
Hospitalizations for heart failure increase CKD patients' risk of kidney failure
Sep 04, 2014
Being hospitalized for heart failure increases kidney disease patients' risks of developing kidney failure or dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of ...
Recommended for you
Current treatment leaves stroke patients at risk
6 hours ago
New research has shown current practices for treating stroke victims may be leaving patients overburdened by their treatment plans putting them at risk of adverse side effects.
Study finds that care lags for people who have a stroke in hospital
15 hours ago
At the first sign of a stroke, time is of the essence. For every minute of delay in treatment, people typically lose almost two million brain cells. Yet a new study presented at the Canadian Stroke Congress reveals that those ...
Innovative stroke patient management system cuts hospital bed usage by more than 25 percent
15 hours ago
An innovative patient management system at the acute stroke unit of Kelowna (BC) General Hospital has reduced the number of stroke patient bed days by more than 25 per cent, according to a study of the system presented at ...
Major bleeds found to be rare for patients with stable CAD
Oct 03, 2014
(HealthDay)—Major bleeding events are rare in patients with stable coronary artery disease (CAD); however, concomitant antiplatelet therapy (APT) when oral anticoagulation is required increases bleeding ...
Genetic test reveals risk of atrial fibrillation and stroke
Oct 03, 2014
Many of those who are genetically predisposed to develop atrial fibrillation, which dramatically raises the risk of stroke, can be identified with a blood test. This is shown by new research from Lund University in Sweden.
Too many stroke patients miss out on the window to regain crucial functions
Oct 03, 2014
Too many stroke patients in Canada are not getting the rehabilitation they need to return to a healthy, active life, according to a new study which will be presented at the Canadian Stroke Congress in Vancouver tomorrow. ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment